We are live on ! Find out more
RI

RTW Investments Portfolio holdings

AUM $10B
1-Year Est. Return 135.35%
This Fund
S&P 500
This Quarter Est. Return
+52.01%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$3.55B
AUM Growth
+$1.23B
Cap. Flow
+$396M
Cap. Flow %
11.15%
Top 10 Hldgs %
48.38%
Holding
82
New
17
Increased
31
Reduced
8
Closed
5

Top Buys

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$115M
2
BAX icon
Baxter International
BAX
+$84.4M
3
CERN
Cerner Corp
CERN
+$81.3M
4
AXSM icon
Axsome Therapeutics
AXSM
+$46.6M
5
TXG icon
10x Genomics
TXG
+$34.7M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$94M
2
ZBH icon
Zimmer Biomet
ZBH
+$67.9M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$51.8M
4
GBT
Global Blood Therapeutics, Inc.
GBT
+$36.8M
5
STAA icon
STAAR Surgical
STAA
+$15M

Sector Composition

Rank Sector Weight
1 Healthcare 91.43%
2 Materials 0.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRAY
76
DELISTED
ViewRay, Inc.
VRAY
$336K 0.01%
150,000
– –
PHGE.WS
77
DELISTED
BiomX Inc. Warrants to purchase one-half of a share of Common Stock
PHGE.WS
$287K 0.01%
600,000
– –
BMY icon
78
Bristol-Myers Squibb
BMY
$132B
– –
-1,685,934
Closed -$94M
SRPT icon
79
Sarepta Therapeutics
SRPT
$1.77B
– –
-529,261
Closed -$51.8M
ZBH icon
80
Zimmer Biomet
ZBH
$18.4B
– –
-691,601
Closed -$67.9M
GBT
81
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-719,489
Closed -$36.8M
1 2 3
4

Similar funds

HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

RTW Investments's Q2 2020 Portfolio in Review

As of Q2 2020, RTW Investments held 82 positions worth $3.55B, up 53% from $2.32B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

RTW Investments deployed $396M of net new capital in Q2 2020, opening 17 new positions and adding to 31 existing holdings. Its largest new stake was Avidity Biosciences: 3,995,000 shares worth $104M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 94% a quarter earlier, followed by Materials.

On the sell side, the largest reduction was STAAR Surgical, an estimated $15M trimmed.

  • RTW Investments's largest Q2 2020 buy was Avidity Biosciences: 3,995,000 shares worth $104M.
  • RTW Investments added most to Axsome Therapeutics in Q2 2020, an estimated $46.6M increase.
  • RTW Investments's biggest Q2 2020 reduction was STAAR Surgical, cutting an estimated $15M.
  • RTW Investments fully exited Bristol-Myers Squibb in Q2 2020, selling an estimated $94M.
  • RTW Investments's ten largest holdings make up 48% of its $3.55B portfolio in Q2 2020.
  • RTW Investments opened 17 new positions and closed 5 in Q2 2020.
  • RTW Investments's portfolio value rose 53% quarter-over-quarter to $3.55B.

Based on RTW Investments's 13F filing for Q2 2020, filed 14 Aug 2020.